Editorial
From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease
NEJM Evidence · 28.10.2025 · 4 (11)
DOI: 10.1056/evide2500255 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM Evidence, erschienen am 28.10.2025. Verfasst von Priya Vart. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Zitieren
APA
Vart, P. (2025). From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease. NEJM Evidence, 4(11). https://doi.org/10.1056/evide2500255
Vancouver
Vart P. From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease. NEJM Evidence. 2025;4(11). doi:10.1056/evide2500255
BibTeX
@article{Vart2025,
author = {Vart, Priya},
title = {From Kidney to Heart — and Beyond — SGLT2 Inhibitors in Chronic Kidney Disease},
journal = {NEJM Evidence},
year = {2025},
volume = {4},
number = {11},
doi = {10.1056/evide2500255}
}
EUVIMED